GREGORY MCNAMARA

Allopathic & Osteopathic Physicians|Electrodiagnostic Medicine JACKSONVILLE, FL NPI 1720051832

General Payments — all program years on this page

$95,218.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 68
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $34,049.24 across 30 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $33,805.0928
Travel and Lodging $123.281
Food and Beverage $120.871

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $33,928.3729
Braeburn Inc. $120.871

By program year

Program yearAmountRecords
2018 $268.693
2021 $18,960.0310
2022 $22,880.0412
2023 $19,060.0313
2024 $34,049.2430

Records — PY2024 (30)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1125601711 Braeburn Inc. $120.87 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137633475 Takeda Pharmaceuticals U.S.A., Inc. $501.67 01/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633477 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633479 Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 01/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633481 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633483 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633485 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633487 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633489 Takeda Pharmaceuticals U.S.A., Inc. $1,003.34 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633491 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633493 Takeda Pharmaceuticals U.S.A., Inc. $501.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633495 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633497 Takeda Pharmaceuticals U.S.A., Inc. $501.67 07/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633499 Takeda Pharmaceuticals U.S.A., Inc. $501.67 08/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633501 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633503 Takeda Pharmaceuticals U.S.A., Inc. $501.67 08/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633505 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633507 Takeda Pharmaceuticals U.S.A., Inc. $501.67 09/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633509 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633511 Takeda Pharmaceuticals U.S.A., Inc. $501.67 10/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633513 Takeda Pharmaceuticals U.S.A., Inc. $501.67 10/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633515 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633517 Takeda Pharmaceuticals U.S.A., Inc. $123.28 11/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137633520 Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633522 Takeda Pharmaceuticals U.S.A., Inc. $501.67 12/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633524 Takeda Pharmaceuticals U.S.A., Inc. $501.67 12/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633526 Takeda Pharmaceuticals U.S.A., Inc. $501.67 12/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633528 Takeda Pharmaceuticals U.S.A., Inc. $2,006.67 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633530 Takeda Pharmaceuticals U.S.A., Inc. $501.67 12/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137633532 Takeda Pharmaceuticals U.S.A., Inc. $501.67 12/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.